logo-loader
viewPressure BioSciences Inc.

Pressure BioSciences CEO sees increased revenue on projects and services in 2018

Pressure BioSciences (OTCMKTS:PBIO) CEO Richard Schumacher tells Proactive Investors the life science group reported a jump in first-quarter revenue thanks to an uptick in instrument sales, and said the company has shrunk its debt.

Schumacher says the company is very proud of their progress, having done $2.2mln in sales in 2017. He says the company has hired more sales staff, and touted a new pressure chamber instrument that allows for a number of "bells and whistles" for researchers

Quick facts: Pressure BioSciences Inc.

Price: 1.99 USD

OTCMKTS:PBIO
Market: OTCMKTS
Market Cap: $4.54 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Pressure BioSciences Inc. named herein, including the promotion by the Company of Pressure BioSciences Inc. in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Pressure BioSciences, The Ohio State University researchers team up to...

Pressure BioSciences (OTCMKTS:PBIO) CEO Richard Schumacher tells Proactive Investors' Christine Corrado that the life sciences company is teaming up with Ohio State University researchers to develop an innovative manufacturing technology that will preserve food and beverages with no...

on 13/7/18

2 min read